Nutex Health (NASDAQ:NUTX) Stock Rating Raised to “Buy” at Wall Street Zen

Wall Street Zen upgraded shares of Nutex Health (NASDAQ:NUTX) from a hold rating to a buy rating in a research note released on Saturday morning,Wall Street Zen reports.

A number of other research firms have also commented on NUTX. Lake Street Capital upped their price target on Nutex Health from $310.00 to $333.00 and gave the company a “buy” rating in a research report on Monday, November 9th. Weiss Ratings cut Nutex Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Thursday. Ladenburg Thalmann & Co. Inc. assumed coverage on Nutex Health in a research report on Monday, October 26th. They set a “buy” rating and a $336.00 price objective for the company. B. Riley Financial raised their price objective on Nutex Health from $325.00 to $357.00 and gave the stock a “buy” rating in a research report on Monday, November 9th. Finally, Zacks Research lowered Nutex Health from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 6th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $342.00.

Nutex Health Trading Up 1.3%

Shares of NASDAQ:NUTX traded up $2.26 during mid-day trading on Friday, reaching $173.67. 79,870 shares of the company’s stock were exchanged, compared to its average volume of 137,339. The firm has a market capitalization of $1.19 billion, a price-to-earnings ratio of 7.42 and a beta of 0.66. The business’s fifty day moving average price is $202.30 and its 200-day moving average price is $152.07. The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.96 and a current ratio of 4.76. Nutex Health has a twelve month low of $83.99 and a twelve month high of $226.16.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings data on Thursday, November 5th. The company reported $5.71 earnings per share for the quarter, topping the consensus estimate of $5.54 by $0.17. The company had revenue of $217.61 million for the quarter, compared to analysts’ expectations of $214.82 million. Nutex Health had a net margin of 20.68% and a return on equity of 34.43%. On average, research analysts predict that Nutex Health will post 27.70 EPS for the current fiscal year.

Insider Transactions at Nutex Health

In other Nutex Health news, Director Scott Saunders sold 203 shares of the company’s stock in a transaction on Friday, September 18th. The shares were sold at an average price of $214.25, for a total transaction of $43,492.75. Following the sale, the director owned 400 shares of the company’s stock, valued at approximately $85,700. This represents a 33.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 44.68% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Kilter Group LLC acquired a new position in shares of Nutex Health in the 2nd quarter valued at about $27,000. Allworth Financial LP acquired a new stake in Nutex Health during the second quarter worth approximately $35,000. GK Wealth Management LLC acquired a new stake in Nutex Health during the third quarter worth approximately $73,000. EverSource Wealth Advisors LLC bought a new stake in Nutex Health in the first quarter worth approximately $83,000. Finally, Voya Investment Management LLC bought a new stake in Nutex Health in the third quarter worth approximately $206,000. 5.32% of the stock is owned by institutional investors.

Nutex Health Company Profile

Nutex Health is a Houston-based healthcare company with two main divisions: a Hospital Division and a Management Services Organization (MSO). Its Hospital Division develops and operates micro-hospitals that provide emergency care and other hospital and outpatient services. Through its MSO, Nutex provides administrative, technology, analytics and other management support to affiliated physician-led organizations. These services support care coordination and population health management. Founded by physician Thomas Vo, who serves as the company’s chairman and chief executive officer, Nutex operates in the United States.